Login Register Cart 0
Generic placeholder image

Current Green Chemistry

Editor-in-Chief

ISSN (Print): 2213-3461
ISSN (Online): 2213-347X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter Article

Eco-friendly Synthesis of Indole Conjugated Chromeno[d]Pyrimidines as Anti-cancer Agents and their Molecular Modelling Studies

Author(s): Venkata Rama Krishnam Raju Datla and Anjali Jha*

Volume 11, Issue 3, 2024

Published on: 20 October, 2023

Page: [221 - 228] Pages: 8

DOI: 10.2174/0122133461267868231018100148

Price: $65

Abstract

Introduction: Many medicinally active new chemical entities depend on indole conjugated chromeno[d]pyrimidine derivatives as a building block. The synthesis of 4-(1H-indol-3-yl)-3,4- dihydro-1H-chromeno[4,3-d]pyrimidine-2,5-dione 4 were achieved in the current study by treating 4- hydroxy-2H-chromen-2-one 1, indole aldehydes 2, and urea/thiourea 3 in the presence of L-proline.

Methods: By adopting the above protocol, we were able to synthesize eight compounds, i.e. 4-(1Hindol- 3-yl)-3,4-dihydro-1H-chromeno[4,3-d]pyrimidine-2,5-diones (4a-4h), in the presence of Lproline as a catalyst in ethanol as solvent for 2-3 hours at 70-75°C with decent yields of 80-85%, and their structures were ascertained by various spectral techniques. They were further screened for their potentiality to inhibit cancer growth in HepG2 and MDA-MD-231 cells.

Results: The scope of the synthesis of biological relevant Indole conjugated Chromeno[ d]Pyrimidines by three-component reaction (MCRs) process was investigated. The most optimised conditions obtained were 0.3 eq of L-proline for 2 hours at 70-75°C which gave the best yield (85%). The few advantages of this newly developed method are excellent yields, no metal catalyst, less toxic solvents, simple workup no chromatographic column purifications. On further screening for their anticancer activities, out of all, the compound 4b displayed noteworthy cytotoxicity with IC50 values of 8.1 and 9.2 μM against HepG2 and MDA-MD-231, respectively. Additionally, in silico studies also supported that compound 4b had favourable binding energy (-7.8 kcal/mol) when compared to the co-crystal ligand (LS5) in inhibiting the human cyclin-dependent kinase 2 (CDK2) protein.

Conclusion: In conclusion, we have developed a simple, convenient, and efficient method for the synthesis of structurally diverse indole conjugated chromeno[d]pyrimidine analogues in the presence of L-proline as catalyst in ethanol as solvent with good yields. Further, the in vitro cytotoxic studies against HepG2 and MDA-MD-231 cells demonstrated that the synthesized compounds had good to reasonable activity, except for compound 4d.

Next »
Graphical Abstract

[1]
Singh, P.K.; Silakari, O. The current status of O-heterocycles: A synthetic and medicinal overview. Chem Med Chem, 2018, 13(11), 1071-1087.
[http://dx.doi.org/10.1002/cmdc.201800119] [PMID: 29603634]
[2]
Agarwal, S.; Sethiya, A.; Soni, J.; Sahiba, N.; Teli, P. An overview of recent advances in the catalytic synthesis of substituted pyrans. Appl. Organomet. Chem., 2022, 36(4), e6604.
[http://dx.doi.org/10.1002/aoc.6604]
[3]
Damghani, F.K.; Kiyani, H.; Pourmousavi, S.A. Green three-component synthesis of merocyanin dyes based on 4- arylideneisoxazol-5(4H)-ones. Curr. Green Chem., 2020, 7(2), 217-225.
[http://dx.doi.org/10.2174/2213346107666200122093906]
[4]
Ma, C.; Zhou, J.Y.; Zhang, Y.Z.; Jiao, Y.; Mei, G.J.; Shi, F. Synergistic‐catalysis‐enabled reaction of 2‐indolymethanols with oxonium ylides for the construction of 3‐indolyl‐3‐alkoxy oxindole frameworks. Chem. Asian J., 2018, 13(17), 2549-2558.
[http://dx.doi.org/10.1002/asia.201800620] [PMID: 29791067]
[5]
Dhavaria, S.; Dhiman, M. A facile one-pot four-component green synthesis of 4-(1H-Indol-2-yl)-4H-chromenes conjugated with phthalazine-1,4-diones. Russ. J. Org. Chem., 2023, 59(4), 726-732.
[http://dx.doi.org/10.1134/S1070428023040231]
[6]
Banerjee, B.; Kaur, M.; Sharma, A.; Singh, A.; Priya, A.; Gupta, V.K.; Jaitak, V. Glycine catalyzed one-pot three-component synthesis of structurally diverse 2-amino substituted pyran annulated heterocycles in aqueous ethanol under refluxed conditions. Curr. Green Chem., 2022, 9(3), 162-173.
[http://dx.doi.org/10.2174/2213346110666221212152202]
[7]
Ziarani, G.M.; Nasab, N.H.; Lashgari, N. Synthesis of heterocyclic scaffolds through 6-aminouracil-involved multicomponent reactions. RSC Advances, 2016, 6, 38827-38848.
[http://dx.doi.org/10.1039/C6RA02834A]
[8]
Keri, R.S.; Hosamani, K.M.; Shingalapur, R.V.; Hugar, M.H. Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety. Eur. J. Med. Chem., 2010, 45(6), 2597-2605.
[http://dx.doi.org/10.1016/j.ejmech.2010.02.048] [PMID: 20356657]
[9]
Mahmoud, N. M. Y.; Abdel-Rahman, B. A. E.; Ahmed, A. F.; May, A. E.; Nabil, M. Y. Synthesis and cytotoxic evaluation of novel chromenes and chromene(2,3-d)pyrimidines. J Appl Pharm Sci, 2020, 10(12), 035-043.
[10]
Javahershenas, R.; Khalafy, J. A new synthesis of pyrrolo[3,2- d]pyrimidine derivatives by a one-pot, three-component reaction in the presence of L-proline as an organocatalyst. Heterocycl. Commun., 2018, 24(1), 37-41.
[http://dx.doi.org/10.1515/hc-2017-0187]
[11]
Mamaghania, M.; Nia, R.H.; Tavakoli, F.; Jahanshahi, P. Recent advances in the MCRs synthesis of chromenes: A review. Curr. Org. Chem., 2018, 22, 1-66.
[http://dx.doi.org/10.2174/138527282201180220105434]
[12]
Basumatary, G.; Mohanta, R.; Bez, G. l-Proline derived secondary aminothiourea organocatalyst for synthesis of coumarin derived trisubstituted methanes: Rate enhancement by bifunctional catalyst over cooperative catalysis. Catal. Lett., 2019, 149(10), 2776-2786.
[http://dx.doi.org/10.1007/s10562-019-02809-4]
[13]
Brahmachari, G.; Mandal, M.; Karmakar, I.; Nurjamal, K.; Mandal, B. ultrasound-promoted expedient and green synthesis of diversely functionalized 6-amino-5-((4-hydroxy-2-oxo-2 h -chromen-3-yl)(aryl)methyl)pyrimidine-2,4(1 H, 3 H)-diones via one-pot multicomponent reaction under sulfamic acid catalysis at ambient conditions. ACS Sustain. Chem.& Eng., 2019, 7(6), 6369-6380.
[http://dx.doi.org/10.1021/acssuschemeng.9b00133]
[14]
Abdolmohammadi, S.; Balalaie, S.; Barari, M.; Rominger, F. Three-component green reaction of arylaldehydes, 6-amino-1,3- dimethyluracil and active methylene compounds catalyzed by Zr(HSO4)4 under solvent-free conditions. Comb. Chem. High Throughput Screen., 2013, 16(2), 150-159.
[PMID: 23092170]
[15]
Bharti, R.; Parvin, T. Molecular diversity from the l-proline-catalyzed, three-component reactions of 4-hydroxycoumarin, aldehyde, and 3-aminopyrazole or 1,3-dimethyl-6-aminouracil. Synth. Commun., 2015, 45(12), 1442-1450.
[http://dx.doi.org/10.1080/00397911.2015.1023900]
[16]
Bharti, R.; Parvin, T. Diversity oriented synthesis of tri-substituted methane containing aminouracil and hydroxynaphthoquinone/hydroxycoumarin moiety using organocatalysed multicomponent reactions in aqueous medium. RSC Advances, 2015, 5(82), 66833-66839.
[http://dx.doi.org/10.1039/C5RA13093J]
[17]
Pratap, R.; Ram, V.J. Natural and synthetic chromenes, fused chromenes, and versatility of dihydrobenzo[h]chromenes in organic synthesis. Chem. Rev., 2014, 114(20), 10476-10526.
[http://dx.doi.org/10.1021/cr500075s] [PMID: 25303539]
[18]
Ellis, G.P.; Weissberger, A.; Taylor, E.C. Chromenes, Chromanones and Chromones. John Wiley: New York, 1977; 2, pp. 11-139.
[19]
Hafez, E.A.A.; Elnagdi, M.H.; Elagamey, A.G.A.; El-Taweel, F.M.A.A. Nitriles in heterocyclic synthesis: novel synthesis of benzo[c]coumarin and of benzo[c]pyrano[3, 2-c]quinoline derivatives. Heterocycles, 1987, 26, 903-907.
[http://dx.doi.org/10.3987/R-1987-04-0903]
[20]
Thomas, N.; Zachariah, S.M. Pharmacological activities of chromene derivatives: An overview. Asian J. Pharm. Clin. Res., 2013, 6(2), 11-15.
[21]
Ying-Jen, C.; Shih-Ming, H.; Ming-Cheng, T.; Jiann-Torng, C.; An-Rong, L.; Ren-Yeong, H.; Chang-Min, L. The anti-fibrotic and anti-inflammatory effects of 2,4-diamino-5-(1-hydroxynaphthalen-2-yl)-5H-chromeno[2,3-b] pyriine-3-carbonitrile in corneal fibroblasts. Pharmacol. Rep., 2020, 72, 115-125.
[http://dx.doi.org/10.1007/s43440-019-00026-9] [PMID: 32016832]
[22]
Hufford, C.D.; Oguntimein, B.O.; Van Engen, D.; Muthard, D.; Clardy, J. Vafzelin and uvafzelin, novel constituents of Uvaria afzelii. J. Am. Chem. Soc., 1980, 102(24), 7365-7367.
[http://dx.doi.org/10.1021/ja00544a037]
[23]
Fuendjiep, V.; Nkengfack, A.E.; Fomum, Z.T.; Sondengam, B.L.; Bodo, B. Conrauinones A and B, two new isoflavones from stem bark of Millettia conraui. J. Nat. Prod., 1998, 61(3), 380-383.
[http://dx.doi.org/10.1021/np970187g] [PMID: 9548880]
[24]
Jean W, J.; Fomum, Z.T.; Tillequin, F.; Libot, F.; Koch, M. Erysenegalenseins B and C, two new prenylated isoflavanones from Erythrina senegalensis J. Nat. Prod., 1995, 58, 105-108.
[25]
Abdolmohammadi, S.; Mirza, B.; Vessally, E. Immobilized TiO2 nanoparticles on carbon nanotubes: an efficient heterogeneous catalyst for the synthesis of chromeno[b]pyridine derivatives under ultrasonic irradiation. RSC Advances, 2019, 9(71), 41868-41876.
[http://dx.doi.org/10.1039/C9RA09031B] [PMID: 35557875]
[26]
Motamedi, R. Synthesis of novel chromeno[4′,3′- b]pyrano[6,5-b]quinoline derivatives. Heterocycl. Commun., 2011, 17(5-6), 169-172.
[http://dx.doi.org/10.1515/HC.2011.047]
[27]
Kumar, U.T.; Bobde, Y.; Sravani, P.; Rangan, K.; Ghosh, B.; Bhattacharya, A. Fused chromeno‐thieno/furo‐pyridines as potential analogs of lamellarin d and their anticancer activity evaluation. ChemistrySelect, 2019, 4, 10726-10730.
[http://dx.doi.org/10.1002/slct.201902946]
[28]
Oliveira-Pintoa, S.; Ludovicoa, P.; Costa, M. Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatment. Bioorg. Chem., 2020, 100, 103942.
[http://dx.doi.org/10.1016/j.bioorg.2020.103942]
[29]
Sarkar, N.; Singh, A.; Kumar, P.; Kaushik, M. Protein kinases: Role of their dysregulation in carcinogenesis, identification and inhibition. Drug Res. (Stuttg.), 2023, 73(4), 189-199.
[http://dx.doi.org/10.1055/a-1989-1856] [PMID: 36822216]
[30]
Borgo, C.; Ruzzen, M. Role of protein kinase CK2 in antitumor drug resistance. J. Exp. Clin. Cancer Res., 2019, 38, 287.
[http://dx.doi.org/10.1186/s13046-019-1292-y] [PMID: 31277672]
[31]
Chen, Y.; Wang, Y.; Wang, J.; Zhou, Z.; Cao, S.; Zhang, J. Strategies of targeting CK2 in drug discovery: Challenges, opportunities, and emerging prospects. J. Med. Chem., 2023, 66(4), 2257-2281.
[http://dx.doi.org/10.1021/acs.jmedchem.2c01523] [PMID: 36745746]
[32]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65(1-2), 55-63.
[http://dx.doi.org/10.1016/0022-1759(83)90303-4] [PMID: 6606682]
[33]
Wan, M.; Zhang, L.; Chen, Y.; Li, Q.; Fan, W.; Xue, Q.; Yan, F.; Song, W. Synthesis and anticancer activity evaluation of novel phenanthridine derivatives. Front. Oncol., 2019, 9, 274.
[http://dx.doi.org/10.3389/fonc.2019.00274] [PMID: 31058081]
[34]
Ghanbari-Ardestani, S.; Khojasteh-Band, S.; Zaboli, M.; Hassani, Z.; Mortezavi, M.; Mahani, M.; Torkzadeh-Mahani, M. The effect of different percentages of triethanolammonium butyrate ionic liquid on the structure and activity of urate oxidase: Molecular docking, molecular dynamics simulation, and experimental study. J. Mol. Liq., 2019, 292, 111318.
[http://dx.doi.org/10.1016/j.molliq.2019.111318]
[35]
Wallace, A.C.; Laskowski, R.A.; Thornton, J.M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. Des. Sel., 1995, 8(2), 127-134.
[http://dx.doi.org/10.1093/protein/8.2.127]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy